BFC Planning’s Adaptive Biotechnologies ADPT Stock Holding History
Bought
Maintained
Sold
Other funds holding ADPT
BFC Planning's ADPT Position: Q3 2026 in Review
BFC Planning increased its Adaptive Biotechnologies (ADPT) stake by 1,329,011% in Q3 2026, buying an estimated $11.4M and bringing the position to 465,189 shares worth $13.4M. The position accounts for 0.53% of the portfolio, ranked #32.
BFC Planning first reported a position in ADPT in Q1 2026 and has held it in 3 quarters since. 244 funds tracked by Wall St. Rank hold ADPT as of Q3 2026.
- BFC Planning held 465,189 shares of Adaptive Biotechnologies worth $13.4M as of Q3 2026.
- BFC Planning bought 465,154 Adaptive Biotechnologies shares in Q3 2026, an estimated $11.4M.
- Adaptive Biotechnologies made up 0.53% of BFC Planning's portfolio in Q3 2026, its #32 holding.
- BFC Planning first reported a position in Adaptive Biotechnologies in Q1 2026 and has held it in 3 quarters since.
- 244 funds tracked by Wall St. Rank held Adaptive Biotechnologies as of Q3 2026.
Based on BFC Planning's 13F filing for Q3 2026, filed 13 Nov 2026.